Metoprolol Succinate Extended-Release Tablets — Class II drug recall D-0269-2023
Terminated recall by Amerisource Health Services LLC, reported 2023-02-22, distributed nationwide. Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer
| Recall number | D-0269-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services LLC, Columbus, OH, United States |
| Recall initiated | 2023-01-11 |
| Classified | 2023-02-15 |
| Reported by FDA | 2023-02-22 |
| Terminated | 2024-05-12 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 68001-0500, 68001-0500-00, 68001-0500-03, 68001-0500-08, 68001-0501, 68001-0501-00, 68001-0501-03, 68001-0501-08, 68001-0502, 68001-0502-00, 68001-0502-03, 68001-0502-08, 68001-0503, 68001-0503-00 |
| Lot numbers | 21143185, 21143193, 21143211 |
| Expiration dates | 2023-02-28, 2023-03-31 |
Product
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b) 500-count bottle, NDC 68001-501-03. Manufactured by Alkem Laboratories Ltd., India. For BluePoint Laboratories
Reason for recall
Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0269-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.